Corbus Pharmaceuticals (CRBP) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 13, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of six directors: Yuval Cohen, Rachelle Jacques, Winston Kung, John Jenkins, Anne Altmeyer, and Yong Ben.

• Proposal to amend the 2024 Equity Compensation Plan, increasing authorized shares by 3,000,000 to a total of 5,000,000.

• Ratification of EisnerAmper LLP as independent auditor for the year ending December 31, 2026.

• Advisory vote on executive compensation for named executive officers.

• Advisory vote on the frequency of future say-on-pay votes, with a recommendation for annual votes.

Board of directors and corporate governance

• Six nominees presented for election to the board, reflecting ongoing governance and oversight.